Labeling Preview? FDA Will Post Changes Being Effected Before Review
Executive Summary
FDA will begin making some postapproval labeling revisions publicly available before they are vetted by the agency under a new policy for "Changes Being Effected" supplements
You may also be interested in...
FDA Opposes Enzi/Kennedy Drug Safety Bill; Action More Likely Through PDUFA
Pending drug safety legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) may do more harm than good, FDA implied in comments submitted to the Senate Health Committee
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
Alzheimer’s, BRAIN Initiative Highlighted In $30 Billion NIH Budget Proposal
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.